Life Science Leader Magazine

APR 2014

The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.

Issue link: https://lifescienceleadermag.epubxp.com/i/287208

Contents of this Issue

Navigation

Page 16 of 61

CLINICAL DEVELOPMENT RENAL SITE NETWORK BIOINFORMATICS & ANALYTICS 844.CKD.ESRD (844.253.3773) | FrenovaRenalResearch.com Operating as a Fresenius Medical Care North America company since 2001, Frenova is your only Phase I-IV clinical development partner dedicated exclusively to renal research. No other research partner works with a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do. When you need to conduct a complete renal clinical program, trust the partner that's completely renal — Frenova Renal Research. n Phase I-IV clinical research - Protocol design and feasibility development - Project management - Site selection, start-up, monitoring and auditing - Regulatory services - Central laboratories n 200+ principal investigators n 250+ dialysis research sites n 183,000+ active ESRD patients n 390,000+ active CKD patients n Historical data on 980,000+ dialysis patients and nearly 400,000 CKD patients n Exceptional resource for assessing protocol feasibility and patient enrollment strategies

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine - APR 2014